2024 3iii Symposium

The Department of Medicine hosted its annual 3iii symposium titled Immunity, Immunotherapy & Immune-related Adverse Events on Thursday 2 May at Davis Auditorium - WEHI.

2024 3iii Symposium

The event brought together a diverse group of clinicians, scientists, researchers, and enthusiasts, culminating in a day filled with engaging discussions, insightful presentations, and valuable networking opportunities.

The symposium kicked off with an inspiring presentation by Ms Chloe Wu, Immunology Clinical Nurse Consultant - RMH, about Immunotherapy-related Adverse Events in the Real World, setting the stage for the day's discussions and provided a solid foundation for the following insightful sessions:

  • Navigating Immune-related Adverse Events in Melanoma Immunotherapy by Dr Lavinia Spain,  (Medical Oncologist, the Peter MacCallum Cancer Centre),
  • Can We Tame the Immune Response to Treat Gastric Cancer without Adverse Outcomes ? byDr Lorraine O’Reilly (Senior Scientist in the Inflammatory Division at the Walter and Eliza Hall Institute of Medical Research),
  • Does Disrupted Iron Homeostasis drive “LongCOVID” ? by Professor Ken Smith (Director of the Walter and Eliza Hall Institute of Medical Research, Head of the Department of Medical Biology at the University of Melbourne),
  • Reflections from Lung CNC - A clinical perspective by Ms Mary Duffy (Advanced Practice, Clinical Nurse Consultant, the Peter MacCallum Cancer Centre),
  • Immunotherapy Skin Toxicities by Dr Vanessa Tran (Fellow in the Dermatology unit at Royal Melbourne Hospital),
  • CAR-T cell therapy for Aggressive Lymphoma: Outcomes and Toxicities by A/Professor Jane Oliaro (Group Leader in the Cancer Immunology Program, Chief Scientist for the Centre of Excellence in Cellular Immunotherapy Translation Laboratory at the Peter MacCallum Cancer Centre),
  • Novel Therapies for Coeliac Disease: Challenges and Opportunities by A/Professor Jason Tye-Din (Laboratory Head, Immunology Division, the Walter and Eliza Hall Institute of Medical Research, Gastroenterologist - The Royal Melbourne Hospital).

Throughout the day, attendees had the opportunity to participate in dynamic discussions featuring prominent experts in various fields. The interactive nature of these sessions encouraged the exchange of ideas among participants. Attendees were treated to cutting-edge research findings and practical case studies, highlighting the latest developments in Immunotherapy-related Adverse Events. Each presentation sparked engaging discussions and inspired new ways of thinking .

In addition to the informative sessions, the symposium provided ample opportunities for networking and collaboration. Attendees had the chance to connect with fellow professionals, exchange contact information, and explore potential partnerships. The relaxed and welcoming atmosphere fostered meaningful connections and laid the groundwork for future collaborations.